UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Expert review of vaccines, 2014-01, Vol.13 (1), p.117-130

2014

Volltextzugriff (PDF)

Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2013-02, Vol.27 (1), p.35-53

2013

Volltextzugriff (PDF)

IMMU-25. SYNERGY BETWEEN TMZ AND INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY TO IMPROVE OS OF IDH1 WILD TYPE MGMT PROMOTOR UNMETHYLATED GBM PATIENTS

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi97-vi97

2021

Volltextzugriff (PDF)

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Genes and immunity, 2022-12, Vol.23 (8), p.255-259

2022

Volltextzugriff (PDF)

IMMU-02. CMV-EXPANDED T-CELLS IN GLIOBLASTOMA PATIENTS: TRANSLATIONAL RESEARCH

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i49-i49

2023

Volltextzugriff (PDF)

INNV-18. MULTIPHASE COMBINED TREATMENT, INCLUDING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY FOR ADULTS WITH GBM: SINGLE INSTITUTE REAL WORLD MEDICAL DATA IN THE LIGHT OF CLINICAL TRIAL RESEARCH DATA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v160-v160

2023

Volltextzugriff (PDF)

QOL-02. MONITORING GBM PATIENT HEALTH-RELATED QUALITY OF LIFE AND QUALITY ADJUSTED LIFE MONTHS DURING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY USING EQ-5D-5L

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v248-v248

2023

Volltextzugriff (PDF)

IMMU-03. Synergy between TMZ and individualized multimodal immunotherapy to improve Overall Survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i81-i81

2022

Volltextzugriff (PDF)

IMMU-07. IMMUNOGENIC CELL DEATH DURING MAINTENANCE CHEMOTHERAPY AND SUBSEQUENT MULTIMODAL IMMUNOTHERAPY FOR GBM

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i99-i100

2018

Volltextzugriff (PDF)

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

Expert review of vaccines, 2009-01, Vol.8 (1), p.51-66

2009

Volltextzugriff (PDF)

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Cancer gene therapy, 2005-03, Vol.12 (3), p.295-303

2005

Volltextzugriff (PDF)

PDCT-15. MULTIMODAL IMMUNOTHERAPY AS PART OF MULTIMODAL TREATMENT FOR DIPG

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi187-vi187

2017

Volltextzugriff (PDF)

DIPG-38. ADDITION OF MULTIMODAL IMMUNOTHERAPY TO COMBINATION TREATMENT STRATEGIES FOR CHILDREN WITH DIPG: FINAL RESULTS OF A COHORT OF CHILDREN

Neuro-oncology (Charlottesville, Va.), 2020-12, Vol.22 (Supplement_3), p.iii294-iii294

2020

Volltextzugriff (PDF)

DIPG-10. MULTIMODAL IMMUNOTHERAPY AS PART OF MULTIMODAL TREATMENT FOR DIPG

Neuro-oncology (Charlottesville, Va.), 2017-06, Vol.19 (suppl_4), p.iv6-iv7

2017

Volltextzugriff (PDF)

ATIM-30. HOW TO MONITOR IMMUNOGENIC CELL DEATH IN PATIENTS WITH GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi7-vi8

2018

Volltextzugriff (PDF)

Danger signals in tumor cells: a risk factor for autoimmune disease?

Expert review of vaccines, 2010-04, Vol.9 (4), p.347-350

2010

Volltextzugriff (PDF)

Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

Cancer gene therapy, 2000-02, Vol.7 (2), p.316-323

2000

Volltextzugriff (PDF)

Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma

JNCI : Journal of the National Cancer Institute, 2007-08, Vol.99 (15), p.1188-1199

2007

Volltextzugriff (PDF)

HGG-05. CAN MULTIMODAL IMMUNOTHERAPY REPLACE RADIOCHEMOTHERAPY IN COMPLETELY RESECTED ADULT GBM?

Neuro-oncology (Charlottesville, Va.), 2017-06, Vol.19 (suppl_4), p.iv23-iv23

2017

Volltextzugriff (PDF)

HG-21NEXT GENERATION IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii52.1-iii52

2016

Volltextzugriff (PDF)

Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report

Immunotherapy, 2015-08, Vol.7 (8), p.855-860

2015

Volltextzugriff (PDF)

Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-κB

International immunology, 1996-04, Vol.8 (4), p.491-498

1996

Volltextzugriff (PDF)

Nitric oxide-induced apoptosis in tumor cells

Advances in Cancer Research, 2001, Vol.82, p.107-131

2001

Volltextzugriff (PDF)

An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules

Cancer gene therapy, 1999-05, Vol.6 (3), p.254-262

1999

Volltextzugriff (PDF)

Nucleocytoplasmic transport of HTLV-1 RNA is regulated by two independent LTR encoded nuclear retention elements

Oncogene, 1998-06, Vol.16 (25), p.3309-3316

1998

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(112)

Sprache

Englisch
(112)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future

IMMU-25. SYNERGY BETWEEN TMZ AND INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY TO IMPROVE OS OF IDH1 WILD TYPE MGMT PROMOTOR UNMETHYLATED GBM PATIENTS

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

IMMU-02. CMV-EXPANDED T-CELLS IN GLIOBLASTOMA PATIENTS: TRANSLATIONAL RESEARCH

INNV-18. MULTIPHASE COMBINED TREATMENT, INCLUDING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY FOR ADULTS WITH GBM: SINGLE INSTITUTE REAL WORLD MEDICAL DATA IN THE LIGHT OF CLINICAL TRIAL RESEARCH DATA

QOL-02. MONITORING GBM PATIENT HEALTH-RELATED QUALITY OF LIFE AND QUALITY ADJUSTED LIFE MONTHS DURING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY USING EQ-5D-5L

IMMU-03. Synergy between TMZ and individualized multimodal immunotherapy to improve Overall Survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

IMMU-07. IMMUNOGENIC CELL DEATH DURING MAINTENANCE CHEMOTHERAPY AND SUBSEQUENT MULTIMODAL IMMUNOTHERAPY FOR GBM

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

PDCT-15. MULTIMODAL IMMUNOTHERAPY AS PART OF MULTIMODAL TREATMENT FOR DIPG

DIPG-38. ADDITION OF MULTIMODAL IMMUNOTHERAPY TO COMBINATION TREATMENT STRATEGIES FOR CHILDREN WITH DIPG: FINAL RESULTS OF A COHORT OF CHILDREN

DIPG-10. MULTIMODAL IMMUNOTHERAPY AS PART OF MULTIMODAL TREATMENT FOR DIPG

ATIM-30. HOW TO MONITOR IMMUNOGENIC CELL DEATH IN PATIENTS WITH GLIOBLASTOMA

Danger signals in tumor cells: a risk factor for autoimmune disease?

Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma

HGG-05. CAN MULTIMODAL IMMUNOTHERAPY REPLACE RADIOCHEMOTHERAPY IN COMPLETELY RESECTED ADULT GBM?

HG-21NEXT GENERATION IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA

Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report

Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-κB

Nitric oxide-induced apoptosis in tumor cells

An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules

Nucleocytoplasmic transport of HTLV-1 RNA is regulated by two independent LTR encoded nuclear retention elements

Aktive Filter

Suchergebnisse filtern